Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Research & Innovation '13

19 Mar 2013 - 19 Mar 2013 - Telford International Centre, UK



Bookmark and Share


This is a one day show featuring 3 Sessions:

Cellular Toxicology in Drug Discovery

Innovation in Cell Culture

Tags & Binders: Tools for Probing Biological Systems

The objective is to provide a communication, education and networking opportunity for scientists engaged in cellular and protein studies including early-phase drug discovery whether in academia, biotech or industry.  The 3 sessions will attract world class speakers discussing challenges and opportunities in developing new technologies.  

The scientific sessions have been chosen as they represent major areas of research important to all areas of drug discovery.  The scientific sessions will be complemented by a poster session, a vendor exhibition with over 35 exhibitors, including an Innovation Zone where fledgling companies will showcase their new technologies.

New Technology Showcase
Calling all Start-up companies, companies with New Technology and vendors with Product Launches.  Talk to us about taking a stand in the Technology Zone.  We have 10 subsidised  spaces available at very reasonable prices, so don’t delay – contact us today. 

Posters
Send your Poster Abstracts in to posters@elrig.org to be included in the Poster Prize.  We would like to encourage all Students & Post Docs to submit their work on a Poster to be judged at the meeting, with Printing of Abstract on Website after event.   Free to enter.

We are continuing to run Free to Register & Attend events

To find out more visit our website: www.elrig.org
Delegates: Register for FREE now: http://www.elrig.org/bookings//regselect/
Exhibitors: Book your stand by contacting: http://www.elrig.org/bookings//select/

For any other information please contact:  Jackie Howard on Jackie.howard@elrig.org 



Further information
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!